Updated Jul 16, 2026
Francis Chris is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $10.53M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-28 | WVE | Wave Life Sciences Ltd. | S — Open-market sale [10b5-1] | 15.3K | $15.00 | $229K |
| 2026-02-28 | WVE | Wave Life Sciences Ltd. | M — Option exercise [10b5-1] | 15.3K | $4.75 | $73K |
| 2026-02-28 | WVE | Wave Life Sciences Ltd. | S — Open-market sale [10b5-1] | 17.9K | $15.09 | $270K |
| 2026-02-28 | WVE | Wave Life Sciences Ltd. | M — Option exercise [10b5-1] | 17.9K | $3.87 | $69K |
| 2026-02-12 | WVE | Wave Life Sciences Ltd. | S — Open-market sale | 1.9K | $13.45 | $25K |
| 2026-02-12 | WVE | Wave Life Sciences Ltd. | A — Grant or award | 38.8K | $0.00 | |
| 2026-01-07 | WVE | Wave Life Sciences Ltd. | S — Open-market sale [10b5-1] | 1.3K | $16.70 | $22K |
| 2026-01-07 | WVE | Wave Life Sciences Ltd. | S — Open-market sale [10b5-1] | 8.1K | $15.92 | $129K |
| 2026-01-07 | WVE | Wave Life Sciences Ltd. | M — Option exercise [10b5-1] | 9.4K | $3.14 | $29K |
| 2025-12-11 | WVE | Wave Life Sciences Ltd. | S — Open-market sale [10b5-1] | 22.5K | $14.08 | $317K |
| 2025-12-11 | WVE | Wave Life Sciences Ltd. | M — Option exercise [10b5-1] | 22.5K | $2.83 | $64K |
| 2025-12-11 | WVE | Wave Life Sciences Ltd. | S — Open-market sale [10b5-1] | 50.0K | $16.00 | $800K |
| 2025-12-11 | WVE | Wave Life Sciences Ltd. | M — Option exercise [10b5-1] | 50.0K | $10.48 | $524K |
| 2025-12-11 | WVE | Wave Life Sciences Ltd. | S — Open-market sale [10b5-1] | 122.3K | $14.20 | $1.74M |
| 2025-12-11 | WVE | Wave Life Sciences Ltd. | M — Option exercise [10b5-1] | 122.3K | $4.75 | $581K |
| 2025-12-11 | WVE | Wave Life Sciences Ltd. | S — Open-market sale [10b5-1] | 17.9K | $15.00 | $268K |
| 2025-12-11 | WVE | Wave Life Sciences Ltd. | M — Option exercise [10b5-1] | 17.9K | $3.87 | $69K |
| 2025-12-11 | WVE | Wave Life Sciences Ltd. | S — Open-market sale [10b5-1] | 37.5K | $14.08 | $528K |
| 2025-12-11 | WVE | Wave Life Sciences Ltd. | M — Option exercise [10b5-1] | 37.5K | $3.14 | $118K |
| 2025-12-11 | WVE | Wave Life Sciences Ltd. | S — Open-market sale [10b5-1] | 9.4K | $15.00 | $141K |
Francis Chris is a corporate insider — currently tracked as Insider. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 19 open-market sales ($10.53M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Francis Chris profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.